Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MCRB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSeres Therapeutics board member Dr. Hans-Juergen Woerle resigns effective May 31
Filed June 1, 2026 · Period ending May 30, 2026 · ~1 min read
Key Changes
-
medium
Dr. Hans-Juergen Woerle resigned from the board of directors and all committee positions effective May 31, 2026. The company explicitly stated the departure involved no disagreement on operations, policies, or practices.
Item 5.02 verify on EDGAR →
Summary
Seres Therapeutics disclosed that board member Dr. Hans-Juergen Woerle resigned from his director position and all committee roles, effective May 31, 2026. The company made clear in its filing that the resignation was not due to any disagreement with management regarding operations, policies, or practices—standard language meant to signal an amicable departure.
For retail investors, board changes merit attention but this appears routine. The explicit 'no disagreement' language suggests this was a planned transition rather than a sudden exit over strategic concerns. However, the company did not disclose the reason for the departure or announce a replacement.
Watch for the company's next proxy filing to see who fills the vacant board seat and whether the departure affects committee composition, particularly audit or compensation oversight. Any clustering of additional board departures in coming months would warrant closer scrutiny.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc. (the “Company”) and on the committees on which he serves, effective May 31, 2026.
Dr. Hans-Juergen Woerle resigned from the board of directors and all committees he served on, with the resignation taking effect May 31, 2026. The filing explicitly states his departure is not due to any disagreement with the company on operations, policies, or practices.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify